These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [Value of a short (7 days) prophylactic course of ganciclovir in the prevention of cytomegalovirus disease after heart transplantation]. Giménez D; María Arizón J; de la Torre J; Anguita M; Escauriaza J; López Granados A; Mesa D; Torres F; Casares J; Concha M; Vallés F Rev Esp Cardiol; 1996 Jan; 49(1):35-40. PubMed ID: 8685510 [TBL] [Abstract][Full Text] [Related]
64. Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation. Szer J; Durrant S; Schwarer AP; Bradstock KF; Gibson J; Arthur C; To LB; Hughes T; Raunow H Intern Med J; 2004 Mar; 34(3):98-101. PubMed ID: 15030456 [TBL] [Abstract][Full Text] [Related]
65. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors. Shah T; Lai WK; Mutimer D Transpl Infect Dis; 2005 Jun; 7(2):57-62. PubMed ID: 16150091 [TBL] [Abstract][Full Text] [Related]
66. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients. Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242 [TBL] [Abstract][Full Text] [Related]
67. Ganciclovir prophylaxis to prevent CMV disease in kidney recipients undergoing anti-lymphocyte globulin treatment for acute rejection. Dickenmann MJ; Kabulbayev K; Steiger J; Cathomas G; Reusser P; Tamm M Clin Microbiol Infect; 2004 Apr; 10(4):337-9. PubMed ID: 15059125 [TBL] [Abstract][Full Text] [Related]
68. Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir. Verma A; Devine S; Morrow M; Chen YH; Mihalov M; Peace D; Stock W; Pursell K; Wickrema A; Yassine M; Jessop E; van Besien K Bone Marrow Transplant; 2003 May; 31(9):813-6. PubMed ID: 12732890 [TBL] [Abstract][Full Text] [Related]
69. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis. Rayes N; Seehofer D; Kahl A; Kokott S; Pratschke J; Frei U; Neuhaus P Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782 [TBL] [Abstract][Full Text] [Related]
70. Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors. Shimokawa T; Morishima Y; Kitaori K; Kato C; Sao H Int J Hematol; 1999 Aug; 70(2):119-26. PubMed ID: 10497851 [TBL] [Abstract][Full Text] [Related]
71. Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation. Wiesner RH; Marin E; Porayko MK; Steers JL; Krom RA; Paya CV Gastroenterol Clin North Am; 1993 Jun; 22(2):351-66. PubMed ID: 8389735 [TBL] [Abstract][Full Text] [Related]
72. [Cytomegalovirus infection in lung transplantation; current status, detection, prophylactic treatment]. Aoe M; Tao H; Yamane M; Toyooka S; Sano Y; Okazaki M; Date H Kyobu Geka; 2007 Oct; 60(11):988-92. PubMed ID: 17926902 [TBL] [Abstract][Full Text] [Related]
73. Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation. Yanada M; Yamamoto K; Emi N; Naoe T; Suzuki R; Taji H; Iida H; Shimokawa T; Kohno A; Mizuta S; Maruyama F; Wakita A; Kitaori K; Yano K; Hamaguchi M; Hamajima N; Morishima Y; Kodera Y; Sao H; Morishita Y Bone Marrow Transplant; 2003 Oct; 32(8):801-7. PubMed ID: 14520425 [TBL] [Abstract][Full Text] [Related]
74. [Should recurrent Cytomegalovirus infections in patients with liver transplantation be treated?]. Tarp BD; Astrup LB Ugeskr Laeger; 1997 May; 159(22):3413-6. PubMed ID: 9199030 [TBL] [Abstract][Full Text] [Related]